Maxim upgraded Adial Pharmaceuticals (ADIL) to Buy from Hold with a $1.50 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADIL:
- Adial Pharmaceuticals Advances AD04 with FDA Support
- Adial announces receipt of final meeting minuts from EOP2 meeting with FDA
- Adial Pharmaceuticals Granted Nasdaq Compliance Extension
- Adial granted a 180 calendar day extension by Nasdaq to regain compliance
- Adial encouraged by U.S. Senate support for extended AUD trial endpoints